Jack W. Schuler
CIK: 0001021412
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 12, 2026BDSX
BIODESIX INC
Purchase(P)Indirect15K shares at avg. $24.47$367K - Aug 11, 2026BDSX
BIODESIX INC
Purchase(P)Indirect13.7K shares at avg. $24.01$329K - Aug 10, 2026BDSX
BIODESIX INC
Purchase(P)Indirect13.9K shares at avg. $24.25$337K - Jun 5, 2026AWHL
Aspira Women's Health Inc.
Purchase(P)Indirect222.2K shares at avg. $0.45$100K - Jan 26, 2026BDSX
BIODESIX INC
Purchase(P)Indirect20K shares at avg. $11.80$236K - Jan 23, 2026BDSX
BIODESIX INC
Purchase(P)Indirect80K shares at avg. $11.81$945K - Jan 22, 2026BDSX
BIODESIX INC
Purchase(P)Indirect82.5K shares at avg. $10.96$904K - Sep 19, 2025BDSX
BIODESIX INC
Purchase(P)Indirect142K shares at avg. $7.04$1000K - Sep 18, 2025BDSX
BIODESIX INC
Purchase(P)Indirect3.1K shares at avg. $6.17$19K - Sep 17, 2025AWHL
Aspira Women's Health Inc.
Purchase(P)Indirect1.1M shares at avg. $0.45$500K - Sep 17, 2025BDSX
BIODESIX INC
Purchase(P)Indirect15.3K shares at avg. $6.04$93K - Aug 29, 2025BDSX
BIODESIX INC
Purchase(P)Indirect3.5M shares at avg. $0.43$1.5M - May 19, 2025BDSX
BIODESIX INC
Purchase(P)Indirect723.2K shares at avg. $0.34$247K - May 16, 2025BDSX
BIODESIX INC
Purchase(P)Indirect4M shares at avg. $0.27$1.1M - Mar 6, 2025AWH
Aspira Women's Health Inc.
Purchase(P)IndirectSenior Secured Convertible Note due 2030
0 shares at avg. $200000.00- - Dec 3, 2024AXDX
Accelerate Diagnostics, Inc
Sale(S)Indirect200K shares at avg. $1.57$314K - Nov 21, 2024BDSX
BIODESIX INC
Purchase(P)Indirect100K shares at avg. $1.23$123K - Nov 20, 2024BDSX
BIODESIX INC
Purchase(P)Indirect200K shares at avg. $1.17$234K - Nov 5, 2024BDSX
BIODESIX INC
Purchase(P)Indirect100.3K shares at avg. $1.36$137K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  BDSX BIODESIX INC | Purchase(P) | 15,000 | $24.47 | $366,992 | Indirect |
| Aug 11, 2026 | BDSX BIODESIX INC | Purchase(P) | 13,700 | $24.01 | $328,911 | Indirect |
| Aug 10, 2026 | BDSX BIODESIX INC | Purchase(P) | 13,900 | $24.25 | $337,029 | Indirect |
| Jun 5, 2026 |  AWHL Aspira Women's Health Inc. | Purchase(P) | 222,222 | $0.45 | $100,000 | Indirect |
| Jan 26, 2026 | BDSX BIODESIX INC | Purchase(P) | 20,000 | $11.80 | $236,064 | Indirect |
| Jan 23, 2026 | BDSX BIODESIX INC | Purchase(P) | 80,000 | $11.81 | $944,672 | Indirect |
| Jan 22, 2026 | BDSX BIODESIX INC | Purchase(P) | 82,465 | $10.96 | $903,561 | Indirect |
| Sep 19, 2025 | BDSX BIODESIX INC | Purchase(P) | 142,045 | $7.04 | $999,997 | Indirect |
| Sep 18, 2025 | BDSX BIODESIX INC | Purchase(P) | 3,056 | $6.17 | $18,854 | Indirect |
| Sep 17, 2025 | AWHL Aspira Women's Health Inc. | Purchase(P) | 1,111,111 | $0.45 | $500,000 | Indirect |
| Sep 17, 2025 | BDSX BIODESIX INC | Purchase(P) | 15,317 | $6.04 | $92,571 | Indirect |
| Aug 29, 2025 | BDSX BIODESIX INC | Purchase(P) | 3,488,372 | $0.43 | $1,500,000 | Indirect |
| May 19, 2025 | BDSX BIODESIX INC | Purchase(P) | 723,239 | $0.34 | $246,624 | Indirect |
| May 16, 2025 | BDSX BIODESIX INC | Purchase(P) | 4,000,000 | $0.27 | $1,070,000 | Indirect |
| Mar 6, 2025 |  AWH Aspira Women's Health Inc. | Purchase(P) Senior Secured Convertible Note due 2030 | 0 | $200000.00 | - | Indirect |
| Dec 3, 2024 |  AXDX Accelerate Diagnostics, Inc | Sale(S) | 200,000 | $1.57 | $314,000 | Indirect |
| Nov 21, 2024 | BDSX BIODESIX INC | Purchase(P) | 100,000 | $1.23 | $122,840 | Indirect |
| Nov 20, 2024 | BDSX BIODESIX INC | Purchase(P) | 200,000 | $1.17 | $234,000 | Indirect |
| Nov 5, 2024 | BDSX BIODESIX INC | Purchase(P) | 100,253 | $1.36 | $136,585 | Indirect |
1-19 of 19 transactions
About SCHULER JACK W
SCHULER JACK W (SEC CIK 0001021412) files insider reports with the SEC as 10% Owner of BIODESIX INC (BDSX), 10% Owner of Aspira Women's Health Inc. (AWHL) and Director of Accelerate Diagnostics, Inc (AXDX).
Signal8 holds 15 ownership filings by SCHULER JACK W, all Form 4s, filed between Nov 6, 2024 and Aug 13, 2026. Those filings report 19 transactions, from Nov 5, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SCHULER JACK W's filings is in LAKE BLUFF, IL.
Recent filings by SCHULER JACK W
- Aug 12, 2026: Open-market purchase of BDSX shares (Form 4, code P).
- Aug 11, 2026: Open-market purchase of BDSX shares (Form 4, code P).
- Aug 10, 2026: Open-market purchase of BDSX shares (Form 4, code P).
- Jun 5, 2026: Open-market purchase of AWHL shares (Form 4, code P).
- Jan 26, 2026: Open-market purchase of BDSX shares (Form 4, code P).
Other insiders filing for BIODESIX INC (BDSX)
- PATIENCE JOHN, Director
- Pestano Gary Anthony, Chief Development Officer
- O'Kane Kieran, Chief Commercial Officer
- Cowie Robin Harper, CFO, Sec'y & Treasurer
- Vazquez Chris, Chief Accounting Officer
- Hutton Scott, President & CEO